RecruitingNot Applicable

Comparison of Sub-maximal Voluntary Isometric Training vs Eccentric Training in Management of De Quervain Tenosynovitis

Pakistan58 participantsStarted 2024-07-18

Plain-language summary

This study is a randomised control trial and the purpose of this study is to compare the effects of Sub-maximal Voluntary Isometric Training vs Eccentric Training in Management of De Quervain Tenosynovitis

Who can participate

Age range

21 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients having history of pain, tenderness in thumb region from 3 weeks or more * Age 21-50 * Both genders * Individuals meeting the diagnostic criteria i.e. * A score of 3 or more out of 7 on De Quervain screening tool. * Positive Wrist hyperflexion and abduction of thumb (WHAT) test * Positive Finkelstein's / Eichhoff's test Exclusion criteria: * Diagnosed cases of Osteoarthritis of 1st CMC joint and Rheumatoid arthritis * C6 cervical radiculopathy * Any systemic inflammatory condition like septic arthritis * Carpal Tunnel Syndrome * Complex regional pain syndrome * Previous surgery impacting the first extensor compartment of the wrist * Corticosteroid injection in the radial wrist region within 3 months of enrolment into the study * If patient had undergone isometric thumb exercises or any strengthening protocol lasting greater than 2 weeks for the management of their current episode of de Quervain's syndrome

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Grip Strength measurement

Timeframe: 4 weeks

Trial details

NCT IDNCT06839690

SponsorFoundation University Islamabad

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-06-01

Contact for this trial

Zahra Nayyer, MS-MSKPT*

0349-8219386 zahranayyar727@gmail.com

View on ClinicalTrials.gov More De Quervain Syndrome trials

Who can participate

Age range

21 Years – 50 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.